Background: Data are sparse and inconsistent regarding whether local thrombolytic therapy (by placement of central venous catheters) reduces mortality, expense or hospital stay in comparison with systemic administration of thrombolytics with acute pulmonary embolism (PE).
results: Among 6279 patients with pulmonary embolism treated with thrombolysis, 1605 (25%) received locally administered therapy. Local catheter-directed thrombolysis (CDT) was reserved for patients with higher co-morbidities. In-hospital all-cause mortality was with CDT was 25.2% vs 11.66% for systemic thrombolysis (OR 2.46, 95% CI 2.13-2.84, P<0.001). Mean total hospitalization charge ($147,245 vs $96,561) as well as length of stay (9 days vs 7 days) was also significantly higher with CDT compared with systemic thrombolysis. In a propensity score-adjusted model, the mortality, hospitalization charge and length of stay while was numerically lower, but still remained significantly higher for CDT in comparison with systemic thrombolysis (Table 1) .
conclusion: CDT compared with systemic thrombolysis for PE doesnot appear to be associated with lower mortality, cost or duration of hospitalization. 
